David C. Gale
Keine laufenden Positionen mehr
Karriereverlauf von David C. Gale
Ehemalige bekannte Positionen von David C. Gale
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INTERSECT ENT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 | 01.08.2009 |
| ARTIVION, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.01.2012 | - |
Ausbildung von David C. Gale
| The University of Alabama | Doctorate Degree |
| Auburn University | Graduate Degree |
| The University of Manchester | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Israel | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 2 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARTIVION, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
- Börse
- Insiders
- David C. Gale
- Erfahrung
